Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in the treatment of autism
IRCT201107281556N27Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of riluzole in Autism Spectrum Disorder (ASD), sponsored by Tehran University of Medical Sciences. Started Sep 2011; status: completed.
02
Drugs
riluzole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201107281556N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107281556N27.